Mankyu Park

Director/Board Member at Coagulant Therapeutics, Inc.

Health Technology

Finance

Consumer Services

Profile

Mankyu is a Principal at DTCP in the Growth Equity team and covers Korea-based investments.
Mankyu came to DTCP from L&S Venture Capital, a leading Korean VC specializing in IT, semiconductors, and display investments.
Prior to that he held positions in the investment banking division of KB Securities and at Partners Group.
Mankyu made investments in IT, AI, Bio/Life science, mobile platforms, and other tech sectors.
Mankyu also led a couple of mid-to-large size deals like Youngin Engineering and Coagulant Therapeutics where top-tier Korean local VCs participated.
Mankyu holds a bachelor’s degree in business administration with concentration on finance from Goizueta Business School, Emory University.

Mankyu Park active positions

Companies	Position	Start
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Coagulant Therapeutics, Inc. is a privately held company that focuses on designing, developing, and commercializing therapeutics for the coagulation cascade and its adjacencies. Coagulant Therapeutics is based in Berkeley, CA. The company's lead product candidate, CT-001, is a next-generation Factor VIIa designed for enhanced efficacy and safety in the setting of acute bleeding. The company is also developing additional therapeutics targeted to APC for the treatment of acute bleeding and other coagulation cascade-related diseases. The company was founded in 2019 by Terry Hermiston, who has been the CEO since then.	Director/Board Member	-

All active positions of Mankyu Park

Former positions of Mankyu Park

Companies	Position	End
DTCP Management GmbH	Corporate Officer/Principal	-

See the detail of Mankyu Park's experience

Training of Mankyu Park

Goizueta Business School-Emory

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mankyu Park's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Coagulant Therapeutics, Inc. Coagulant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Coagulant Therapeutics, Inc. is a privately held company that focuses on designing, developing, and commercializing therapeutics for the coagulation cascade and its adjacencies. Coagulant Therapeutics is based in Berkeley, CA. The company's lead product candidate, CT-001, is a next-generation Factor VIIa designed for enhanced efficacy and safety in the setting of acute bleeding. The company is also developing additional therapeutics targeted to APC for the treatment of acute bleeding and other coagulation cascade-related diseases. The company was founded in 2019 by Terry Hermiston, who has been the CEO since then.	Health Technology
DTCP Management GmbH	Finance